Evidence map›Paper›PMID 36212619›Full record

ArticleCase reports in genetics2022

De Novo Heterozygous Mutation in FGFR2 Causing Type II Pfeiffer Syndrome.

Rafat Mosalli, Alfia Fatma, Mohammed A Almatrafi, Mayada Mazroua, Bosco Paes

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Rafat MosalliDepartment of Pediatrics, Umm Al Qura University, Makkah, Saudi Arabia.ORCID https://orcid.org/0000-0002-4590-2820
Alfia FatmaWomen's Health Center, International Medical Center, Jeddah, Saudi Arabia.
Mohammed A AlmatrafiDepartment of Pediatrics, Umm Al Qura University, Makkah, Saudi Arabia.
Mayada MazrouaDepartment of Pediatrics, International Medical Center, Jeddah, Saudi Arabia.
Bosco PaesDepartment of Pediatrics (Neonatal Division), McMaster University Medical Center, Hamilton, ON, Canada.
King Abdullah International Medical Research Center · SAUmm al-Qura University · SAMcMaster University Medical Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pfeiffer syndrome (PS) is an autosomal dominant disorder with three subtypes stemming from heterozygous mutations in the fibroblast growth factors FGFR1 and FGFR2. The subtypes overlap with heterogeneous clinical manifestations and variable prognosis dependent on neurological and respiratory compromise that impact short- and long-term outcomes and survival. We present a male, term infant with type II PS that was diagnostically suspected antenatally based on three-dimensional ultrasonographic findings that were confirmed postnatally by craniofacial tomography and magnetic resonance imaging. A new generation sequencing panel identified a unique

Identifiers

PMID36212619
PMCPMC9537020
OpenAlexW4283687582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.